Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)
TRLV trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.11
-2.69% on the day
Market cap
$1.9B
Small cap
Revenue · 2025
$1.2B
-0.4% on 2024
Net income · 2025
-$116.4M
-9.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | TRLV on NYSE |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001754195 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.2B |
| Net income | -$116.4M |
| Operating income | $143.5M |
| Net margin | -9.9% |
| Operating margin | 12.1% |
| Revenue growth | -0.4% |
| Cash | $255.5M |
| Total assets | $2.7B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2025-06-30 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy | DEF 14A | 2026-06-25 |
Source: SEC EDGAR submissions feed, 414 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.2% |
| 1 month | -11.9% |
| 3 months | +21.5% |
| Year to date | +17.6% |
| 1 year | +26.2% |
| From 52-week high | -21.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RLX | RLX Technology Inc. | $1.71 | -0.58% | $2.1B |
| CRON | Cronos Group Inc. Common Share | $3.20 | -0.31% | $1.2B |
| RGC | Regencell Bioscience Holdings Limited | $8.19 | +14.87% | $4.1B |
| DFTX | Definium Therapeutics Inc. Common Shares | $34.38 | -2.33% | $4.6B |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier